Changes in tumor hypoxia measured with a double hypoxic marker technique
- 1 December 2000
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 48 (5) , 1529-1538
- https://doi.org/10.1016/s0360-3016(00)00787-2
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancerRadiotherapy and Oncology, 1998
- A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85Radiotherapy and Oncology, 1998
- Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiotherapy and Oncology, 1996
- Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizersSeminars in Radiation Oncology, 1996
- Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicityRadiotherapy and Oncology, 1995
- Intratumoral pO2 predicts survival in advanced cancer of the uterine cervixRadiotherapy and Oncology, 1993
- Tumor oxygenation and reoxygenation during radiation theraphy: Their importance in predicting tumor responseInternational Journal of Radiation Oncology*Biology*Physics, 1986
- RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCERThe Lancet, 1977
- The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in RadiotherapyThe British Journal of Radiology, 1953